Cargando…

Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy

Dry eye disease (DED) is among the most common ocular disorders affecting tens of millions of individuals worldwide; however, the condition remains incompletely understood and treated. Valuable insights have emerged from multidisciplinary approaches, including immunometabolic analyses, microbiome an...

Descripción completa

Detalles Bibliográficos
Autores principales: Heidari, Mostafa, Noorizadeh, Farsad, Wu, Kevin, Inomata, Takenori, Mashaghi, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780511/
https://www.ncbi.nlm.nih.gov/pubmed/31514344
http://dx.doi.org/10.3390/jcm8091439
_version_ 1783457147663679488
author Heidari, Mostafa
Noorizadeh, Farsad
Wu, Kevin
Inomata, Takenori
Mashaghi, Alireza
author_facet Heidari, Mostafa
Noorizadeh, Farsad
Wu, Kevin
Inomata, Takenori
Mashaghi, Alireza
author_sort Heidari, Mostafa
collection PubMed
description Dry eye disease (DED) is among the most common ocular disorders affecting tens of millions of individuals worldwide; however, the condition remains incompletely understood and treated. Valuable insights have emerged from multidisciplinary approaches, including immunometabolic analyses, microbiome analyses, and bioengineering. Furthermore, we have seen new developments in clinical assessment approaches and treatment strategies in the recent past. Here, we review the emerging frontiers in the pathobiology and clinical management of DED.
format Online
Article
Text
id pubmed-6780511
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67805112019-10-30 Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy Heidari, Mostafa Noorizadeh, Farsad Wu, Kevin Inomata, Takenori Mashaghi, Alireza J Clin Med Review Dry eye disease (DED) is among the most common ocular disorders affecting tens of millions of individuals worldwide; however, the condition remains incompletely understood and treated. Valuable insights have emerged from multidisciplinary approaches, including immunometabolic analyses, microbiome analyses, and bioengineering. Furthermore, we have seen new developments in clinical assessment approaches and treatment strategies in the recent past. Here, we review the emerging frontiers in the pathobiology and clinical management of DED. MDPI 2019-09-11 /pmc/articles/PMC6780511/ /pubmed/31514344 http://dx.doi.org/10.3390/jcm8091439 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Heidari, Mostafa
Noorizadeh, Farsad
Wu, Kevin
Inomata, Takenori
Mashaghi, Alireza
Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy
title Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy
title_full Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy
title_fullStr Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy
title_full_unstemmed Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy
title_short Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy
title_sort dry eye disease: emerging approaches to disease analysis and therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780511/
https://www.ncbi.nlm.nih.gov/pubmed/31514344
http://dx.doi.org/10.3390/jcm8091439
work_keys_str_mv AT heidarimostafa dryeyediseaseemergingapproachestodiseaseanalysisandtherapy
AT noorizadehfarsad dryeyediseaseemergingapproachestodiseaseanalysisandtherapy
AT wukevin dryeyediseaseemergingapproachestodiseaseanalysisandtherapy
AT inomatatakenori dryeyediseaseemergingapproachestodiseaseanalysisandtherapy
AT mashaghialireza dryeyediseaseemergingapproachestodiseaseanalysisandtherapy